Text size Teva CEO Kåre Schultz has been predicting a national opioid settlement for years. Christopher Goodney/Bloomberg Teva Pharmaceutical Industries CEO Kåre Schultz has, for years, been predictin...
Tag: specialized drugs
Pfizer’s New CFO David Denton Negotiated One of the Biggest Healthcare Deals in History
Pfizer on Monday named a new chief financial officer with a resume that hints at the company’s plans to spend big with its Covid-19 vaccine windfall. David Denton is taking up the CFO role at Pfizer (...
Pfizer, Moderna and J&J Face Shareholder Pressure to Broaden Covid-19 Vaccine Access
Socially conscious investors and global-health activists are turning to shareholders to press Covid-19 vaccine manufacturers Pfizer Inc., Moderna Inc. and Johnson & Johnson to make more of their s...
Novavax’s Revenue Falls Short. Management Expects a Surge.
Text size A doctor handles a vial holding a potential coronavirus vaccine at a Novavax lab in 2020. Andrew Caballero-Reynolds/AFP via Getty Images The Covid-19 vaccine maker Novavax expects sales of b...
Moderna and Novavax Stocks Get Whacked by Supreme Court’s Vaccine Decision
Text size A nurse takes a Moderna Covid-19 vaccines ready to be administered at a vaccination site Apu Gomes/AFP via Getty Images Novavax stock and shares of other vaccine makers fell Friday after the...
Moderna Shipped 800 Million Covid-19 Vaccine Doses in 2021
Text size Syringes with Moderna’s Covid-19 vaccine. Thomas Lohnes/Getty Images Moderna said in a letter to shareholders on Tuesday that it had shipped approximately 800 million doses of its Covi...
Moderna Faces Challenges Beyond the Covid Vaccine. Its Stock Is Still a Buy for the Long Term.
In 2019, four pharmaceutical giants shared virtually all of the $33 billion worth of vaccine revenue earned worldwide. The pandemic has upended the vaccine business. Moderna has sold or contracted to ...